Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Redx Pharma - Capital Network: Entering the Clinical Stage

Redx Pharma (REDX.LON), a drug discovery and development company focused on oncology, immunology and infectious diseases, is about to move its two lead candidates into the clinical stage.
Redx Pharma - Capital Network: Entering the Clinical Stage

Redx pharma (REDX.LON) owns RXC005 global IP rights, with key composition-of-matter patents expected to extend up until 2035

Full report is available via Capital Network website


Register here to be notified of future REDX Company articles
View full REDX profile View Profile

Redx Pharma Plc Timeline

Related Researches

bio.png
March 08 2017

Avacta (AVCT.LON), a UK-based biotechnology company, has developed an innovative proteinscaffold platform, with potential applications in the life sciences research, diagnostic and therapeutic markets.

no_picture_pai.jpg
April 04 2017

On April 3rd Avacta (AVCT.LON) released the results of a pre-clinical study showing that Affimers have an immunogenicity profile comparable to widely used biotech drugs.  This leaves Avacta (AVCT.LON) on track to move their immuno-oncology therapeutic Affimer into the clinic by 2019.

concepta.png
October 26 2016

Concepta is a small UK-based company that focuses on the development and commercialization of its medical diagnostic device MyLotus. The device, a consumer good, has been developed to improve the probability of conception for women with unexplained infertility (not pregnant after 12+ months trying).

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use